The Importance of Mg 2+ ‐Free State in Nucleotide Exchange of Oncogenic K‐Ras Mutants
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
The Importance of Mg 2+ ‐Free State in Nucleotide Exchange of Oncogenic K‐Ras Mutants ; day:01 ; month:09 ; year:2022 ; extent:1
Chemistry - a European journal ; (01.09.2022) (gesamt 1)
- Creator
-
Pálfy, Gyula
Menyhárd, Dóra K.
Ákontz‐Kiss, Hanna
Vida, István
Batta, Gyula
Tőke, Orsolya
Perczel, András
- DOI
-
10.1002/chem.202201449
- URN
-
urn:nbn:de:101:1-2022090115254274721939
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pálfy, Gyula
- Menyhárd, Dóra K.
- Ákontz‐Kiss, Hanna
- Vida, István
- Batta, Gyula
- Tőke, Orsolya
- Perczel, András
Other Objects (12)
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Excited-state observation of active K-Ras reveals differential structural dynamics of wild-type versus oncogenic G12D and G12C mutants
The relationship between oncogenic KRas and wild-type Ras activity and signaling
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS promotes malignant brain tumors in zebrafish
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Excited-state observation of active K-Ras reveals differential structural dynamics of wild-type versus oncogenic G12D and G12C mutants
The relationship between oncogenic KRas and wild-type Ras activity and signaling
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS promotes malignant brain tumors in zebrafish
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Excited-state observation of active K-Ras reveals differential structural dynamics of wild-type versus oncogenic G12D and G12C mutants
The relationship between oncogenic KRas and wild-type Ras activity and signaling
A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers
Immune modulatory effects of oncogenic KRAS in cancer
Oncogenic KRAS promotes malignant brain tumors in zebrafish
K-Ras protein as a drug target
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
Graded inhibition of oncogenic Ras-signaling by multivalent Ras-binding domains
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation